With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.189442-78-2,1-Boc-N-methoxy-N-methylpiperidine-3-carboxamide,as a common compound, the synthetic route is as follows.
Step 2: To a solution of compound B (4.7 g, 17.2 mMol) in 70 ml of THF at 0 C. (under N2) was added a 3.0 M (11.5 ml, 34.5 mMol) solution of Methyl Magnesium Bromide in THF. After the addition was complete, the cooling bath was removed and the resulting mixture was allowed to rise to room temperature where it was allowed to stir overnight. The resulting mixture was quenched with a saturated aqueous KHSO4 solution and diluted with EtOAc. The organic phase was washed with brine, dried over MgSO4, filtered and evaporated to dryness. The crude residue was passed through a plug of silica gel and eluted with 5-20% EtOAc/Hexane. Yield: 2.37 g, approximately 60%. H NMR (500 MHz, CDCl3) 4.10 (d, J=12.0 Hz, H), 3.92 (s, H), 2.94 (dd, J=10.3, 13.3 Hz, H), 2.82-2.77 (m, H), 2.52-2.48 (m, H), 2.18 (s, 3H), 1.98 (dd, J=3.6, 12.9 Hz, H), 1.73-1.69 (m, H), 1.56-1.44 (m, 11H).
189442-78-2 1-Boc-N-methoxy-N-methylpiperidine-3-carboxamide 22248320, apiperidines compound, is more and more widely used in various.
Reference£º
Patent; Ledeboer, Mark; Pierce, Albert; Bemis, Guy; Farmer, Luc; Wang, Tiansheng; Messersmith, David; Duffy, John; Salituro, Francesco; Wang, Jian; US2006/183761; (2006); A1;,
Piperidine – Wikipedia
Piperidine | C5H11N – PubChem